Boxer Capital as of Sept. 30, 2019
Portfolio Holdings for Boxer Capital
Boxer Capital holds 49 positions in its portfolio as reported in the September 2019 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Spark Therapeutics | 11.6 | $160M | 1.7M | 96.98 | |
Mirati Therapeutics | 9.7 | $134M | 1.7M | 77.91 | |
Beigene (BGNE) | 8.2 | $113M | 925k | 122.46 | |
Immunomedics | 6.7 | $92M | 7.0M | 13.26 | |
Odonate Therapeutics Ord | 6.3 | $88M | 3.4M | 26.03 | |
Amarin Corporation (AMRN) | 3.9 | $53M | 3.5M | 15.16 | |
Allakos (ALLK) | 3.9 | $53M | 675k | 78.63 | |
Dbv Technologies S A (DBVT) | 3.3 | $46M | 5.3M | 8.60 | |
Springworks Therapeutics (SWTX) | 3.3 | $45M | 2.1M | 21.68 | |
Sarepta Therapeutics (SRPT) | 3.0 | $41M | 550k | 75.32 | |
Solid Biosciences | 2.9 | $40M | 3.9M | 10.34 | |
Medicines Company | 2.7 | $38M | 750k | 50.00 | |
Esperion Therapeutics (ESPR) | 2.6 | $36M | 975k | 36.66 | |
Gossamer Bio (GOSS) | 2.5 | $35M | 2.1M | 16.79 | |
Uniqure Nv (QURE) | 2.5 | $34M | 865k | 39.36 | |
Ptc Therapeutics I (PTCT) | 2.5 | $34M | 1.0M | 33.82 | |
BioMarin Pharmaceutical (BMRN) | 2.2 | $30M | 450k | 67.40 | |
Argenx Se (ARGX) | 1.6 | $23M | 200k | 113.96 | |
Atreca Inc Cl A (BCEL) | 1.5 | $21M | 1.7M | 12.24 | |
Wave Life Sciences (WVE) | 1.5 | $21M | 1.0M | 20.53 | |
Milestone Pharmaceuticals (MIST) | 1.5 | $21M | 1.1M | 18.65 | |
Amicus Therapeutics (FOLD) | 1.4 | $19M | 2.3M | 8.02 | |
Rocket Pharmaceuticals (RCKT) | 1.2 | $17M | 1.5M | 11.65 | |
Apellis Pharmaceuticals (APLS) | 1.2 | $17M | 700k | 24.09 | |
Prevail Therapeutics Ord | 1.0 | $14M | 1.1M | 12.28 | |
Kura Oncology (KURA) | 0.9 | $13M | 845k | 15.17 | |
Global Blood Therapeutics In | 0.9 | $12M | 250k | 48.52 | |
Zogenix | 0.9 | $12M | 300k | 40.04 | |
Bellus Health | 0.8 | $11M | 1.8M | 6.39 | |
Akero Therapeutics (AKRO) | 0.8 | $11M | 483k | 22.75 | |
Kadmon Hldgs | 0.7 | $10M | 4.0M | 2.52 | |
Voyager Therapeutics (VYGR) | 0.6 | $8.6M | 500k | 17.21 | |
Avrobio Ord (AVRO) | 0.6 | $8.5M | 600k | 14.12 | |
Immunomedics Inc Cmn Stk cmn | 0.6 | $8.0M | 600k | 13.26 | |
Lexicon Pharmaceuticals (LXRX) | 0.6 | $7.5M | 2.5M | 3.01 | |
Achillion Pharmaceuticals | 0.5 | $7.2M | 2.0M | 3.60 | |
Ideaya Biosciences (IDYA) | 0.5 | $6.9M | 764k | 9.00 | |
La Jolla Pharmaceuticl Com Par | 0.5 | $6.8M | 775k | 8.80 | |
Matinas Biopharma Holdings, In (MTNB) | 0.5 | $6.4M | 10M | 0.63 | |
Cymabay Therapeutics | 0.5 | $6.4M | 1.3M | 5.12 | |
Mei Pharma | 0.3 | $4.9M | 2.9M | 1.68 | |
Syndax Pharmaceuticals (SNDX) | 0.2 | $3.0M | 400k | 7.47 | |
Arcus Biosciences Incorporated (RCUS) | 0.2 | $2.7M | 300k | 9.10 | |
Mersana Therapeutics (MRSN) | 0.2 | $2.7M | 1.7M | 1.58 | |
Kiniksa Pharmaceuticals (KNSA) | 0.2 | $2.5M | 291k | 8.51 | |
Kalvista Pharmaceuticals (KALV) | 0.2 | $2.3M | 200k | 11.60 | |
Cellectar Biosciences | 0.1 | $1.8M | 920k | 2.00 | |
Prothena (PRTA) | 0.1 | $624k | 80k | 7.84 | |
Novus Therapeutics | 0.0 | $201k | 324k | 0.62 |